|
Primary Antibodies
DRD3 Antibody
Background
The DRD3 Dopamine Receptor is expressed in brain regions associated with cognitive, emotional, and endocrine functions. DRD3 mediates the effects of drugs used in the treatment of schizophrenia and Parkinson's disease. DRD3 also binds BP897, a potent inhibitor of drug-craving and cocaine-seeking behaviors. Mutations in DRD3 lead to sodium retention in the kidney, resulting in hypertension and increased locomotor activity in mice. Multiple isoforms of DRD3 are produced by alternative splicing.
Additional Names
DRD3, D, D3DR, ETM1, FET1, d3 dopamine receptor, d3nf, dopamine 3 receptor, dopamine d3 receptor, dopamine receptor d3, drd3
|
Description
Left: Immunohistochemistry staining of DRD3 in brain, cortex (formalin-fixed paraffin-embedded) using DRD3 antibody.
|
Purification
Immunoaffinity Chromatography
Clonality / Clone
This is a polyclonal antibody.
Host
DRD3 antibody was raised in rabbit.
Please use anti-rabbit secondary antibodies.
Immunogen
DRD3 antibody was raised against the 3rd cytoplasmic domain of DRD3. (Human)
Application
DRD3 antibody can be used for detection of DRD3 by IHC-parafin (20 μg/ml).
Tested Application
IHC
Buffer
DRD3 antibody is supplied in PBS, 0.1% sodium azide.
Storage
DRD3 antibody can be stored at -70˚C for long term storage, and 4˚C for short term storage.
Species Reactivity
H
Formulation
Weight: 50 μg
Volume: 50 μl
Concentration: 1 mg/ml
Short Description
Dopamine Receptor D3
This product belongs to the following categories:
Datasheet 09-01W
|
|
